Jorge Amador Berlanga Acosta

Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds

Jorge Amador Berlanga Acosta, W. Savigne, Calixto Valdez, 2006, International wound journal.

Quantitative Studies of the Evolution of Diabetic Foot Lesions under EGF Treatment by Magnetic Resonance Imaging

Jorge Amador Berlanga Acosta, G. Nieto, C. Cabal-Mirabal, 2014 .

Epidermal growth factor and growth hormone-releasing peptide-6: combined therapeutic approach in experimental stroke.

Jorge Amador Berlanga Acosta, J. S. Alba, R. M. Coro-Antich, 2013, Restorative neurology and neuroscience.

Linking the Advanced Glycation Endproducts/ Receptor for Advanced Glycation Endproducts Pathway in Diabetics with Inflammation and Topical Antiinflammatory Treatments of Chronic Wounds

J. Stechmiller, L. Cowan, Jorge Amador Berlanga Acosta, 2010 .

Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wounds

Jorge Amador Berlanga Acosta, A. G. Ojalvo, A. Barreto, 2016 .

Role of epidermal growth factor and growth hormone-releasing peptide-6 in acceleration of renal tissue repair after kanamycin overdosing in rats

Jorge Amador Berlanga Acosta, L. Núñez, S. Salgueiro, 2014 .

Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction

D. Armstrong, D. G. Armstrong, Jorge Amador Berlanga Acosta, 2017, International wound journal.

The pro‐inflammatory environment in recalcitrant diabetic foot wounds

Jorge Amador Berlanga Acosta, W. Savigne, P. López-Saura, 2008, International wound journal.

Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds

Jorge Amador Berlanga Acosta, W. Savigne, Calixto Valdez, 2006, International wound journal.